Staking out novelty on the genomic frontier

Current Opinion in Chemical Biology

Volumn 6, Issue 4, 2002, Pages 418-426

  Quinn Senger, Kerry E ^a   Ramachandran, Ravi ^a   Rininger, Joseph A ^a   Kelly, Karen M ^a   Lewin, David A ^a  

^a CURAGEN CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PURINE RECEPTOR;

CPG ISLAND; DRUG TOLERANCE; GENE EXPRESSION; GENE FUNCTION; GENE SEQUENCE; GENE STRUCTURE; GENETIC TRANSCRIPTION; GENOMICS; HUMAN; NONHUMAN; PHARMACOGENOMICS; PROTEOMICS; REVIEW; SEQUENCE HOMOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; TOXICOGENOMICS;

EID: 0036680067     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(02)00344-7     Document Type: Review

References (66)

1. The rush to Oklahoma
2. Small GTP-binding proteins
3. Identification of 23 complementation groups required for post- translational events in the yeast secretory pathway
4. A ras-like protein is required for a post-Golgi event in yeast secretion
5. Four additional members of the ras gene superfamily isolated by an oligonucleotide strategy: Molecular cloning of YPT-related cDNAs from a rat brain library
6. The complexity of the Rab and Rho GTP-binding protein subfamilies revealed by a PCR cloning approach
7. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd
8. The impact of microbial genomics on antimicrobial drug development
9. The complete sequence of the mucosal pathogen Ureaplasma urealyticum
10. Life with 6000 genes
11. Microbial genome sequencing
12. An integrated approach for finding overlooked genes in yeast
13. Genome annotation: From sequence to biology
14. Creating the gene ontology resource: Design and implementation
15. Initial sequencing and analysis of the human genome
16. The sequence of the human genome
17. Gene structure prediction and alternative splicing analysis using genomically aligned ESTs
18. CpG-rich islands and the function of DNA methylation
19. CpG islands in vertebrate genomes
20. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells
21. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs
22. The scanning model for translation: An update
23. A catalogue of splice junction sequences
24. Categorization and characterization of transcript-confirmed constitutively and alternatively spliced introns and exons from human
25. Selenocysteine
26. Large-scale predictions of secretory proteins from mammalian genomic and EST sequences
27. Human gene discovery through experimental definition of transcribed regions of the human genome
28. Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element
29. Predicting splice variant from DNA chip expression data
30. Genome-wide detection of alternative splicing in expressed sequences of human genes
31. Intergenic mRNA molecules resulting from trans-splicing
32. The many roles of an RNA editor
33. Molecular and functional characterization of human P2X(2) receptors
34. A cSNP map and database for human chromosome 21
35. Catalog of 258 single-nucleotide polymorphisms (SNPs) in genes encoding three organic anion transporters, three organic anion-transporting polypeptides, and three NADH: Ubiquinone oxidoreductase flavoproteins
36. Quantification of single nucleotide polymorphisms: A novel method that combines primer extension assay and capillary electrophoresis
37. A single nucleotide polymorphism in protein tyrosine phosphatase PTP-1B is associated with protection from diabetes or impaired glucose tolerance in Oji-Cree
38. Novel mutation in exon 18 of the cartilage oligomeric matrix protein gene causes a severe pseudoachondroplasia
39. New developments in microarray technology
40. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays
41. Open systems: Panoramic views of gene expression
42. Application of industrial scale genomics to discovery of therapeutic targets in heart failure
43. Differential gene expression technologies for identifying surrogate markers of drug efficacy and toxicity
44. Genomics: Implications for toxicology
45. Toxicogenomics and drug discovery: Will new technologies help us produce better drugs
46. Discovery in toxicology: Mediation by gene expression array technology
47. Challenges and limitations of gene expression profiling in mechanistic and predictive toxicology
48. The principles and practice of toxigenomics: Applications and opportunities
49. Genomics and proteomics analysis of acetaminophen toxicity in mouse liver
50. Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro
51. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione
52. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo
53. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae
54. Functional organization of the yeast proteome by systematic analysis of protein complexes
55. Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry
56. Analysis of yeast protein kinases using protein chips
57. Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae
58. Functional proteins from a random-sequence library